Abstract
The treatment of nausea and vomiting in patients receiving high doses of irradiation and/or chemotherapeutic agents as preparation for hematopoietic stem cell transplantation is discussed.
Such patients have very high rates of both early and delayed emesis. Based on the available evidence, it is recommended that 5-HT3 receptor antagonists be used to combat emesis in this setting. Continued research is also required to define the optimal antiemetic strategy for these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agura ED, Cleveland Brown M, Schaffer R, Donaldson G, Shen DD (1995) Anti-emetic efficacy and pharmacokinetics of intravenous ondansetron infusion during chemotherapy conditioning for bone marrow transplant. Bone Marrow Transplant 16: 213–222
Barbounis V, Koumakis G, Vassilomanolakis M, Hatzichristou H, Tsousis S, Efremidis AP (1995) A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation 3: 301–306
Bosi A, Guidi S, Messori A et al (1993) Ondansetron versus chlorpromazine for preventing emesis in born marrow transplant recipients: a double-blind randomized study. J Chemother 5: 191–196
Di Piro CV, Sanal SM, Harkness KT et al (1996) The anti-emetic efficacy of intravenous ondansetron at conventional versus low dose in women with early stage breast cancer. Proc Am Soc Clin Oncol 15: 540
Feuvret L, Jammet P, Campana F, Cosset JM, Fourquet A (1994) Interet du granisetron dans la prevention des troubles digestifs lors des irradiations corporelles totales. Bull Cancer/Radiother 81: 41–44
Grant Prentice H, Cunningham S, Gandhi L, Cunningham J, Collis C, Harmon MD (1995) Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 15: 445–448
Hewitt M, Cornish J, Pamphilon D, Oakhill A (1991) Effective emetic control during conditioning of children for bone marrow transplantation using ondansetron, a 5-HT3 receptor antagonist. Bone Marrow Transplant 7: 431–433
Hunter AE, Prentice HG, Pothecary K et al (1991) Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. Bone Marrow Transplant 7: 439–441
Jurgens H, McQuade B (1992) Ondansetron as prophylaxis for chemotherapy and radiotherapy induced emesis in children. Oncology 49: 279–285
Koleck P, Wachowiak J, Beshari SE (1993) Ondansetron as an effective drug in prophylaxis of chemotherapy-induced emesis in children. Acta Haematol Pol 24: 115–122
Okamoto S, Takahashi S, Tanosaki R et al (1996) Granisetran in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. Bone Marrow Transplant 17: 679–683
Or R, Drakos P, Nagler A, Naparstek E, Kapelushnik J, Cass Y (1994) The anti-emetic efficacy and tolerability of tropisetron in patients with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation. Support Care Cancer 2: 245–248
Schwella N, Konig V, Schwerdtfeger R et al (1994) Ondansetron for efficient emesis control during total body irradiation. Bone Marrow Transplant 13: 169–171
Spitzer TR, Deeg HJ, Torrisi J et al (1990) Total body irradiation induced emesis is universal after small dose fractions (120 cGy) and is not cumulative dose related. Proc ASCO 9: 14
Spitzer TR, Bryson JC, Cirenza E et al (1994) Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J Clin Oncol 12: 2432–2435
Tiley C, Powles R, Catalano J et al (1992) Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation. Leuk Lymph 7: 317–321
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Spitzer, T.R., Grunberg, S.M., Dicato, M.A. (1998). Antiemetic Strategies for High-Dose Chemoradiotherapy-Induced Nausea and Vomiting. In: Gralla, R.J., Tonato, M., Roila, F. (eds) Perugia Consensus Conference on Antiemetic Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72137-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-72137-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72139-7
Online ISBN: 978-3-642-72137-3
eBook Packages: Springer Book Archive